3 No-Brainer Stocks to Buy in September
Don't want to think too hard about your investing decisions? Then go with the stocks of highly profitable companies with strong growth prospects.
Three Motley Fool contributors identified several stocks that fit this description. Here's why they think Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer healthcare stocks to buy in September.
David Jagielski (Eli Lilly): Eli Lilly continually gives investors reason to become even more bullish on its already plentiful growth opportunities. Right now, it's all about the growing upside and potential for tirzepatide -- the active ingredient in its type 2 diabetes and weight loss drugs, Mounjaro and Zepbound.
Source Fool.com
Vertex Pharmaceuticals Inc. Stock
€469.30
1.380%
With 42 Buy predictions and 1 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 475 € shows a slightly positive potential of 1.21% compared to the current price of 469.3 € for Vertex Pharmaceuticals Inc..
